Physician profile
Luis Rizo
NPI 1164668497
$401.02
in general payments reported to CMS, 2019-2025
11 companies · $198 in 2025
The $198 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $39.95 · 2024: $163 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $401.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $401.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $90.23 | 2024-2025 | |
| Xeris Pharmaceuticals, INC. | $74.41 | 2024-2025 | Gvoke Hypopen |
| Hologic Sales and Service, LLC | $61.57 | 2023-2025 | Thinprep 2000 Processor, Aptima, Myosure Tissue Removal Device |
| Lilly USA, LLC | $32.11 | 2025 | Mounjaro |
| Corcept Therapeutics | $27.36 | 2024 | Korlym |
| Dexcom, INC. | $22.64 | 2025 | Dexcom G6 Transmitter |
| Ambu INC. | $21.96 | 2025 | |
| Sumitomo Pharma America, INC. | $19.95 | 2023 | Myfembree |
| Melinta Therapeutics, LLC | $17.73 | 2025 | Rezzayo |
| Dynavax Technologies Corporation | $16.63 | 2024 | Heplisav-B |
| Tandem Diabetes Care, INC. | $16.43 | 2024 | T:Slim X2 Insulin Pump With Control-Iq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Rizo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.